These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 20967345)
21. Synergy between cigarette smoking and human papillomavirus type 16 in cervical cancer in situ development. Gunnell AS; Tran TN; Torrång A; Dickman PW; Sparén P; Palmgren J; Ylitalo N Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2141-7. PubMed ID: 17057029 [TBL] [Abstract][Full Text] [Related]
22. Staurosporine-induced apoptosis of HPV positive and negative human cervical cancer cells from different points in the cell cycle. Bernard B; Fest T; Prétet JL; Mougin C Cell Death Differ; 2001 Mar; 8(3):234-44. PubMed ID: 11319606 [TBL] [Abstract][Full Text] [Related]
23. Dehydroepiandrosterone inhibits the proliferation and induces the death of HPV-positive and HPV-negative cervical cancer cells through an androgen- and estrogen-receptor independent mechanism. Girón RA; Montaño LF; Escobar ML; López-Marure R FEBS J; 2009 Oct; 276(19):5598-609. PubMed ID: 19702826 [TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor (VEGF) up-regulates epidermal growth factor receptor (EGF-R) in cervical cancer in vitro: this action is mediated through HPV-E6 in HPV-positive cancers. Mathur RS; Mathur SP Gynecol Oncol; 2005 Apr; 97(1):206-13. PubMed ID: 15790460 [TBL] [Abstract][Full Text] [Related]
25. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells. Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029 [TBL] [Abstract][Full Text] [Related]
26. Integrated HPV genomes tend to integrate in gene desert areas in the CaSki, HeLa, and SiHa cervical cancer cell lines. Diao MK; Liu CY; Liu HW; Li JT; Li F; Mehryar MM; Wang YJ; Zhan SB; Zhou YB; Zhong RG; Zeng Y Life Sci; 2015 Apr; 127():46-52. PubMed ID: 25747255 [TBL] [Abstract][Full Text] [Related]
27. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening. Adams M; Jasani B; Fiander A Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517 [TBL] [Abstract][Full Text] [Related]
28. Co-localization of the tumor-suppressor protein p53 and human papillomavirus E6 protein in human cervical carcinoma cell lines. Liang XH; Volkmann M; Klein R; Herman B; Lockett SJ Oncogene; 1993 Oct; 8(10):2645-52. PubMed ID: 8397367 [TBL] [Abstract][Full Text] [Related]
29. Detection and typing of human papillomavirus in cervical cancer in the Thai. Bhattarakosol P; Poonnaniti A; Niruthisard S J Med Assoc Thai; 1996 Dec; 79 Suppl 1():S56-64. PubMed ID: 9071068 [TBL] [Abstract][Full Text] [Related]
30. Season, sun, sex, and cervical cancer. Hrushesky WJ; Sothern RB; Rietveld WJ; Du Quiton J; Boon ME Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1940-7. PubMed ID: 16103441 [TBL] [Abstract][Full Text] [Related]
31. Cellular response to chemotherapy and radiation in cervical cancer. Saxena A; Yashar C; Taylor DD; Gercel-Taylor C Am J Obstet Gynecol; 2005 May; 192(5):1399-403. PubMed ID: 15902120 [TBL] [Abstract][Full Text] [Related]
32. Monitoring cellular responses upon fatty acid exposure by Fourier transform infrared spectroscopy and Raman spectroscopy. Najbjerg H; Afseth NK; Young JF; Bertram HC; Pedersen ME; Grimmer S; Vogt G; Kohler A Analyst; 2011 Apr; 136(8):1649-58. PubMed ID: 21347493 [TBL] [Abstract][Full Text] [Related]
34. Elevated glucose-6-phosphate dehydrogenase expression in the cervical cancer cases is associated with the cancerigenic event of high-risk human papillomaviruses. Hu T; Li YS; Chen B; Chang YF; Liu GC; Hong Y; Chen HL; Xiyang YB Exp Biol Med (Maywood); 2015 Oct; 240(10):1287-97. PubMed ID: 25616277 [TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus-mediated expression of complement regulatory proteins in human cervical cancer cells. Khan A; Hussain S; Iyer JK; Kaul A; Bonnewitz M; Kaul R Eur J Obstet Gynecol Reprod Biol; 2023 Sep; 288():222-228. PubMed ID: 37572452 [TBL] [Abstract][Full Text] [Related]
36. Biochemical investigations of human papillomavirus-infected cervical fluids. Choi S; Park HK; Min GE; Kim YH Microsc Res Tech; 2015 Mar; 78(3):200-6. PubMed ID: 25545188 [TBL] [Abstract][Full Text] [Related]
37. Biochemical fingerprints of human papillomavirus infection and cervical dysplasia using cervical fluids: Spectral pattern investigation. Kim YH; Chang B; Choi JH; Park HK; Choi S Microsc Res Tech; 2016 Oct; 79(10):966-972. PubMed ID: 27435509 [TBL] [Abstract][Full Text] [Related]
39. Lopinavir shows greater specificity than zinc finger ejecting compounds as a potential treatment for human papillomavirus-related lesions. Zehbe I; Richard C; Lee KF; Campbell M; Hampson L; Hampson IN Antiviral Res; 2011 Aug; 91(2):161-6. PubMed ID: 21669231 [TBL] [Abstract][Full Text] [Related]
40. A1E reduces stemness and self-renewal in HPV 16-positive cervical cancer stem cells. Kwon T; Bak Y; Ham SY; Yu DY; Yoon DY BMC Complement Altern Med; 2016 Feb; 16():42. PubMed ID: 26832364 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]